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Abstract. 
 
ERGIC-53, a homo-oligomeric recycling 
protein associated with the ER–Golgi intermediate 
compartment (ERGIC), has properties of a mannose-
selective lectin in vitro, suggesting that it may function 
as a transport receptor for glycoproteins in the early 
secretory pathway. To investigate if ERGIC-53 is in-
volved in glycoprotein secretion, a mutant form of this 
protein was generated that is incapable of leaving the 
ER. If expressed in HeLa cells in a tetracycline-induc-
ible manner, this mutant accumulated in the ER and 
retained the endogenous ERGIC-53 in this compart-
ment, thus preventing its recycling. Mistargeting of 
ERGIC-53 to the ER did not alter the gross morphol-
ogy of the early secretory pathway, including the distri-
bution of 
 
b9
 
-COP. However, it impaired the secretion of 
one major glycoprotein, identified as the precursor of the 
lysosomal enzyme cathepsin C, while overexpression of 
wild-type ERGIC-53 had no effect on glycoprotein 
secretion. Transport of two other lysosomal enzymes 
and three post-Golgi membrane glycoproteins was un-
affected by inactivating the recycling of ERGIC-53. The 
results suggest that the recycling of ERGIC-53 is re-
quired for efficient intracellular transport of a small 
subset of glycoproteins, but it does not appear to be es-
sential for the majority of glycoproteins.
Key words: cathepsin C • ER–Golgi intermediate 
compartment • glycoproteins • recycling • transport 
receptor
 
S
 
ecretory
 
 proteins are synthesized in the rough en-
doplasmic reticulum and packaged into COPII-
coated transport vesicles budding from the transi-
tional elements of the rough ER (Schekman and Orci,
1996). ER export involves transport signals (Kappeler et al.,
1997; Nishimura and Balch, 1997), at least one of which di-
rectly binds COPII coats (Kappeler et al., 1997). Signal–
coat interaction, either directly or indirectly, may lead to
the known concentration of proteins during ER export
(Mizuno and Singer, 1993; Balch et al., 1994). After losing
their coat, COPII vesicles fuse with the ER–Golgi inter-
mediate compartment (ERGIC)
 
1
 
 (according to the stable
compartment/vesicle hypothesis) or fuse with one another
to form the ERGIC (according to the maturation hypothe-
sis) (for reviews see Bannykh and Balch, 1997; Farquhar
and Hauri, 1997; Glick et al., 1997). The ERGIC is now
best defined by the marker protein ERGIC-53 (Hauri and
Schweizer, 1992, 1997) and in part also harbors the small
GTPases rab1 (Griffiths et al., 1994; Saraste et al., 1995)
and rab2 (Chavrier et al., 1990), the KDEL receptor (Grif-
fiths et al., 1994), the SNARE syntaxin 5/Sed5 and rbet1
(Banfield et al., 1994; Zhang et al. 1997), and p23 (Rojo et al.,
1997).
Protein transport from ERGIC to 
 
cis
 
-Golgi is mediated
by a COPI-dependent step, either reflecting a vesicular
step or maturation (Bannykh and Balch, 1997; Presley
et al., 1997; Scales et al., 1997). The ERGIC is the first site
of segregation of anterograde and retrograde transported
proteins (Aridor et al., 1995; Itin et al., 1995
 
a
 
; Tang et al.,
1995). Retrograde transport from ERGIC to ER as well as
from 
 
cis
 
-Golgi to ERGIC/ER is mediated by COPI-coated
vesicles (Gaynor et al., 1994; Letourneur et al., 1994;
Townsley and Pelham, 1994; Aridor et al., 1995). Some of
the retrograde transported proteins are packaged into
COPI-coated vesicles by direct interaction of their cytoso-
lic dilysine ER retrieval signal with COPI components
(Cosson and Letourneur, 1994; Kappeler et al., 1997; Tis-
dale et al., 1997).
It appears unlikely that all membrane proteins directly
interact with COPII during ER exit, and secretory pro-
teins, for reason of topology, are unable to bind cytosolic
coats. Signal-mediated ER export of these proteins there-
fore requires transport receptors, the nature of which has
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remained elusive. Several features of the lectin ERGIC-53
suggest that this nonglycosylated membrane protein may
operate as a transport receptor for glycoproteins in the
early secretory pathway (Itin et al., 1996). ERGIC-53 is
synthesized as a homo-oligomeric type I membrane protein
(Schweizer et al., 1988; Schindler et al., 1993) and constitu-
tively recycles between the ERGIC and ER (Lippincott-
Schwartz et al., 1990; Saraste and Svensson, 1991; Aridor
et al., 1995; Itin et al., 1995
 
a
 
). The recycling of ERGIC-53
is controlled by a complex interplay of targeting signals,
including a cytosolic dilysine ER retrieval signal interact-
ing with COPI vesicle coat proteins (Schindler et al., 1993;
Itin et al., 1995
 
b
 
; Kappeler et al., 1997; Tisdale et al., 1997)
and a cytosolic ER exit determinant binding to COPII ves-
icle coat proteins (Kappeler et al., 1997). The luminal do-
main of ERGIC-53 comprises a carbohydrate recognition
domain (CRD) that exhibits homologies to the mamma-
lian post-Golgi vesicle protein VIP36 and to leguminous
lectins over a stretch of 
 
z
 
200 amino acids (Fiedler and
Simons, 1994). The CRD is more than 90% homologous in
ERGIC-53 from 
 
Xenopus
 
, rat, and man (Lahtinen et al.,
1996). ERGIC-53 preferentially binds mannose in a calcium-
dependent way, and mutating conserved amino acids in the
CRD known to be essential for carbohydrate binding in legu-
minous lectins abolished mannose binding (Arar et al., 1995;
Itin et al., 1996). These in vitro binding studies established
ERGIC-53 as a mannose-selective lectin. The carbohydrate
specificity in conjunction with the recycling properties led us
to propose that ERGIC-53 may collect newly synthesized
high-mannose glycoproteins in the ER and thereby facilitate
their transport to the ERGIC (Itin et al., 1996).
In the present study, we asked if ERGIC-53 is required
for glycoprotein secretion. To test this, we studied protein
secretion in HeLa cells overexpressing a mutant of ER-
GIC-53 that is unable to leave the ER and compared it
with that of HeLa cells overexpressing wild-type ERGIC-
53. By using a tetracycline-driven inducible system for
transient expression of stably transfected proteins, we ob-
served that mistargeting of ERGIC-53 to the ER impairs
the secretion of a major glycoprotein identified as pro-
cathepsin C.
 
Materials and Methods
 
Reagents
 
Antibodies used were: mAb G1/93 against human ERGIC-53 (Schweizer
et al., 1988), mAb G1/296 against human p63 (Schweizer et al., 1993,
1995), mAb G1/139 against human Lamp1 (Schweizer et al., 1988), mAb
G1/221 against human transferrin receptor (produced by the mouse hybri-
doma technique and confirmed by peptide sequencing of the purified anti-
gen [Schweizer et al., 1988]), mAb HBB 3/153 against human small intesti-
nal aminopeptidase N (Hauri et al., 1985), mAb A1/118 against monkey
GPP130 (Linstedt et al., 1997), mAb G1/133 against human giantin (Lin-
stedt and Hauri, 1993), mAb 9E10 against a c-myc epitope (American
Type Culture Collection, Rockville, MD: ATCC CRL 1729), an mAb
against human 
 
a
 
-glucosidase (kindly provided by J. Fransen, University of
Nijmegen, The Netherlands), an mAb against human cathepsin D (Calbi-
ochem, La Jolla, CA), rabbit polyclonal antisera against human ERGIC-53
(Itin et al., 1995
 
b
 
), and rat cathepsin C (kindly provided by E. Kominami,
Juntendo University, Tokyo, Japan). The neoglycoprotein fluorescein-
labeled (FITC) Man-BSA was kindly provided by A.C. Roche and
M. Monsigny (University Orléans, France) (Itin et al., 1996). Concanavalin
A (Con A)–Sepharose was from Pharmacia Biotech (Uppsala, Sweden).
Protease inhibitors (used concentrations: 1 
 
m
 
g/ml pepstatin, 1 
 
m
 
g/ml apro-
tinin, 1 
 
m
 
g/ml benzamidin, 1 
 
m
 
g/ml antipain, and 0.2 mM phenylmethylsul-
fonyl fluoride) and tetracycline were from Sigma Chemical Co. (St. Louis,
MO), and [
 
35
 
S]methionine was from New England Nuclear (Boston, MA).
 
Cells
 
HtTA-1 HeLa cells expressing the chimeric tetracycline (tet) regulatable
transcription activator were kindly provided by H. Bujard (Zentrum für
Molekulare Biologie, Heidelberg, Germany). They were cultured in DME
supplemented with 10% heat-inactivated FCS, 100 IU/ml penicillin, 100
 
m
 
g/ml streptomycin, and 400 
 
m
 
g/ml geneticin (GIBCO BRL, Life Tech-
nologies, Basel, Switzerland). FAO cells were cultured as HeLa cells but
without geneticin.
 
cDNA Constructs
 
Myc-tagged ERGIC-53 in pECE vector (p53cmyc; Itin et al., 1995
 
a
 
) is
termed KKFF in this study. An ERGIC-53 construct with its cytoplasmic
tail mutated to R2A6KKAA in pECE (Itin et al.,1995
 
b
 
) was cut with
AccI/XbaI, and the small fragment was subcloned into the AccI/XbaI site
of KKFF. This construct is termed KKAA. Both KKFF and KKAA were
cloned as SalI/XbaI fragments into the EcoRI site of the tetracycline-
inducible expression plasmid pUHD10-3 (kindly provided by H. Bujard).
This plasmid carries a human cytomegalovirus minimal promoter fused to
seven repetitive tet operator sequences (tetO) upstream of the cloning site
(Gossen and Bujard, 1992; Resnitzky et al., 1994).
 
Generation of Stably Transformed HtTa-1 Cell Lines
 
The procedure of Damke et al. (1995) was followed. Briefly, 1 
 
3 
 
10
 
6
 
 cells
were seeded into a 10-cm culture dish the day before transfection. After a
4-h preincubation with 2 
 
m
 
g/ml tet, the cells were transfected with the
cDNA (20 
 
m
 
g) encoding either KKFF or KKAA under the control of the
tTA promoter (pUHD10-3 plasmid) together with the plasmid pBSpac
(1 
 
m
 
g) containing the puromycin resistance gene (de la Luna et al., 1988)
by using the calcium phosphate precipitation method (Sambrook and Pol-
lack, 1974). Clones were selected and expanded in the presence of 2 
 
m
 
g/ml
tet, 500 ng/ml puromycin (Fluka AG, Buchs, Switzerland), and 400 
 
m
 
g/ml
geneticin (GIBCO BRL). Puromycin-resistant clones were screened by
immunofluorescence after incubation for 48 h in the absence of tet.
 
Immunofluorescence Microscopy
 
All experiments were carried out in eight-well multichamber glass slides
(Miles Labs, Naperville, IL). The cells were plated and cultured for 48 h in
the presence or absence (
 
6
 
) of tet and then fixed with paraformaldehyde,
permeabilized with Triton X-100, and stained with antibodies using the in-
direct immunofluorescence procedure (Schweizer et al., 1988). For double
immunofluorescence with FITC-Man-BSA and anti–ERGIC-53, the pro-
cedure of Itin et al. (1996) was used.
 
Metabolic Labeling, Immunoprecipitation,
and Immunoblotting
 
Cells plated into 6-cm dishes were incubated 
 
6 
 
tet (2 
 
m
 
g/ml) for 48 h and
labeled with 100 
 
m
 
Ci [
 
35
 
S]methionine for 30 min followed by a chase of
varying length in the presence of 10 mM unlabeled methionine. ER-
GIC-53 was immunoprecipitated from Triton X-100–solubilized cells with
mAb G1/93 against ERGIC-53 or mAb 9E10 against c-myc according to
Schweizer et al. (1988). For the immunoprecipitation of cathepsin C,
PBS-washed cells were solubilized in 10 mM phosphate, pH 7.4, 1% Triton
X-100, 0.2% SDS, 0.2 mM PMSF (solubilization buffer) for 1 h on ice and
centrifuged at 50,000 
 
g
 
 for 1 h at 4
 
8
 
C. The resulting supernatant was incu-
bated for 2 h with 2 
 
m
 
l of anti–rat cathepsin C antibody prebound to pro-
tein A–Sepharose CL4B beads, and the beads were washed three times
with solubilization buffer. Cathepsin C was also immunoprecipitated from
either methanol-precipitated culture medium or from a glycoprotein frac-
tion prepared from the culture medium (see below). Immunoisolated pro-
teins were subjected to SDS-PAGE and visualized by fluorography using
Kodak X-omat AR films (Rochester, NY).
 
Digestion with Endoglycosidases
 
Immunoprecipitated proteins were boiled for 3 min in endoglycosidase H
(endo H) buffer (1% SDS, 100 mM Na-citrate, pH 5.3) or 
 
N
 
-glycosidase F 
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(endo F) buffer (50 mM Na
 
2
 
HPO
 
4
 
, pH 7.2, 10 mM EDTA, 0.1% SDS, 1%
Triton X-100). After cooling to room temperature, the samples were sup-
plemented with additional buffer containing protease inhibitors, incu-
bated with 3 
 
m
 
l of endo H or endo F for 24 h at 37
 
8
 
C, and analyzed by
SDS-PAGE.
 
Isolation and Analysis of Secreted Glycoproteins
 
The cells were cultured in 6-cm dishes for 48 h 
 
6 
 
tet (2 
 
m
 
g/ml) and sub-
jected to the pulse-chase [
 
35
 
S]methionine labeling procedure. The chase
medium was serum-free DME containing 10 mM methionine. Tetracy-
cline was present or not during the preincubation, labeling, and chase pe-
riods, depending on whether noninducible or inducible conditions were
studied. At the end of the chase, the medium was collected and centri-
fuged for 10 min at 10,000 rpm in a microfuge to remove cell debris. The
medium was then incubated under constant agitation for 1 h at room tem-
perature with 30 
 
m
 
l Con A beads in 1 ml Con A buffer (20 mM Tris-HCl,
pH 7.5, 500 mM NaCl, 1 mM of CaCl
 
2
 
, MnCl
 
2
 
 and MgCl
 
2
 
). The beads
were washed four times with 1 ml Con A buffer, and glycoproteins were
eluted by incubating the beads for 30 min at room temperature with 100 
 
m
 
l
of 0.5 M
 
 a
 
-methyl-mannoside in Con A buffer under constant agitation.
Glycoproteins were separated by one-dimensional SDS-PAGE and visu-
alized by fluorography. Alternatively, secreted glycoproteins were ana-
lyzed by two-dimensional gel electrophoresis. The glycoproteins were iso-
lated with Con A beads, precipitated with methanol, and separated in the
first dimension for 15 h on a 110-mm pH 3–10 linear isoelectric focusing
immobiline gradient gel DryStrip according to the instructions of the man-
ufacturer (Pharmacia Biotech). A 10% SDS–polyacrylamide gel run with
constant voltage was used in the second dimension.
 
Isolation and Microsequencing of the
57-kD Glycoprotein
 
Cells overexpressing the KKFF construct were plated into six 15-cm
dishes. At 80% confluence, the cells were incubated with serum-free
DME for 24 h. The medium was collected, centrifuged, and incubated
with Con A beads as above. Eluted glycoproteins were separated on a
7–10% SDS–polyacrylamide gel and blotted onto a polyvinyl difluoride
membrane (Millipore Corp., Bedford, MA) in 25 mM Tris, 190 mM gly-
cine, 10% methanol for 3 h. Glycoproteins were stained with Coomassie
blue R-250 for 1 h and destained in 50% methanol. The 57-kD area was
excised and incubated with trypsin (Fernandez et al., 1992). Tryptic pep-
tides were separated on a 1.0-mm Vydac218TP51 reverse-phase column in
0.1% TFA-acetonitrile and sequenced on a pulse–liquid phase sequencer
(model 477A; PE Applied Biosystems, Foster City, CA) (Jenö et al.,
1995).
 
Subcellular Fractionation
 
HeLa cells were fractionated by Nycodenz gradient centrifugation (Kap-
peler et al., 1997). Briefly, cells of four 
 
z
 
80% confluent 15-cm plates were
homogenized with a ball-bearing homogenizer and the postnuclear super-
natant was loaded onto a 13–29% (wt/vol) linear Nycodenz gradient. Af-
ter centrifugation at 25,500 rpm for 3 h (model TST-28.17 rotor; Kontron
Elektronik GmbH, Eching, Germany), 14 fractions were collected, and
organelle marker proteins were analyzed by SDS-PAGE followed by im-
munoblotting with specific antibodies (ECL procedure).
 
Results
 
Approach to Study the Involvement of ERGIC-53 in 
Protein Secretion
 
If ERGIC-53 operates as a transport receptor for glyco-
proteins in the early secretory pathway, mutations affect-
ing its localization and recycling properties may lead to
impaired glycoprotein secretion. In this study, we have
tested this notion by mislocalizing ERGIC-53 to the ER.
We have previously described a cytoplasmic tail mutant of
ERGIC-53 (termed GMAA) that is unable to leave the
ER. In this mutant, the two COOH-terminal phenylala-
nines were mutated to alanines, which inactivates the ER
exit determinant of ERGIC-53 (Kappeler et al., 1997).
The similar mutant KKAA used in the present study be-
haves identically to GMAA. It also accumulates in the ER
(Kappeler, F., and H.-P. Hauri, unpublished). KKAA and
wild-type ERGIC-53, termed KKFF, were tagged with a
c-myc epitope at the NH
 
2
 
 terminus. It is important to note
that the two constructs differed only in their cytosolic do-
main, whereas the luminal and transmembrane domains
were identical (Fig. 1 
 
A
 
). Since ERGIC-53 is a homo-
oligomeric protein, overexpression of KKAA in the ER
can be expected to block the recycling of endogenous ER-
GIC-53 by mixed oligomer formation and thereby inacti-
vate its (putative) transport receptor function.
To minimize a possible upregulation of a compensatory
mechanism for the lack of functional ERGIC-53, the mu-
tants were expressed in the tet-controlled inducible system
of Gossen and Bujard (1992). cDNAs encoding KKFF or
KKAA were subcloned into the plasmid pUHD10-3
downstream of a human cytomegalovirus minimal pro-
Figure 1. Expression of KKFF and KKAA in stably transformed
HtTA-1 HeLa cells. (A) Schematic representation of the two ER-
GIC-53 constructs used in this study. Both carry a c-myc epitope
after the signal sequence cleavage site (Itin et al., 1995b). KKFF
is the wild-type ERGIC-53. KKAA has the luminal and trans-
membrane domains of ERGIC-53 and a mutated cytoplasmic do-
main. The amino acid residues of the cytosolic tails are indicated
in the single letter code. (B) Tet-dependent inducibility of the
KKFF and KKAA constructs. Cells were incubated for 48 h 6
tet, pulsed for 30 min with [35S]methionine, and immunoprecipi-
tated with an mAb against ERGIC-53, and the proteins were sep-
arated by 4–10% SDS-PAGE followed by fluorography. (C)
Coimmunoprecipitation of the KKAA construct with endoge-
nous ERGIC-53. KKAA cells were cultured in the absence of tet
in medium containing [35S]methionine for the indicated times.
Immunoprecipitation with an antibody against the myc epitope
(M, present only in the KKAA construct) coprecipitated endoge-
nous ERGIC-53 (e) with the KKAA construct (m) (lanes 2 and
4). For reference, immunoprecipitation was also done with G1/93
(G), which recognizes an epitope present on both the KKAA
construct and endogenous ERGIC-53 (lanes 1 and 3). The un-
equal signals are due to the known low immunoprecipitation effi-
ciency of the anti-myc antibody. Proteins were visualized by fluo-
rography after SDS-PAGE. 
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moter fused to seven repetitive tetO sequences (Damke
et al., 1996). This vector allows inducible expression of
cDNAs when transfected into HtTA-1 HeLa cells express-
ing constitutively a chimeric transactivator (tTA). In these
cells and in the absence of tet, tTA binding to tetO effi-
ciently activates transcription of the gene. In contrast,
when tet is present, a conformational change in the tet re-
pressor domain prevents tTA from binding to the tetO se-
quences, and the promoter is silent. Both constructs were
transfected into HtTA-1 cells together with a puromycin-
selectable marker (de la Luna et al., 1988). After selection
and subcloning under noninducible conditions, positive
clones were screened by immunofluorescence microscopy
for the expression of recombinant protein 48 h after with-
drawal of tet using an mAb against the c-myc epitope ex-
clusively present on the transgenes.
 
Inducible Expression of KKAA in the ER
 
To analyze the inducibility of the ERGIC-53 constructs,
stably transfected clones were incubated 
 
6 
 
tet for 48 h and
metabolically labeled with [
 
35
 
S]methionine for 30 min.
ERGIC-53  was immunoprecipitated with an mAb and ana-
lyzed by SDS-PAGE (Fig. 1 
 
B
 
). Under inducible conditions
(
 
2
 
tet), the rate of synthesis of both constructs was several-
fold higher when compared with the endogenous ERGIC-53:
up to fivefold for KKFF and up to 10-fold for KKAA. Simi-
lar values were obtained when total amounts of ERGIC-53
proteins were quantified by immunoblotting with a poly-
clonal antibody against ERGIC-53 (not shown). In the pres-
ence of tet, no (KKFF) or very little (KKAA) recombinant
protein was detectable, demonstrating the tightness of the
expression system under noninducible conditions.
We next analyzed by subcellular fractionation if the
envisaged mislocalization of the KKAA construct to the
ER was achieved. Postnuclear supernatants of KKFF or
KKAA cells cultured for 48 h 
 
6 
 
tet were separated by Ny-
codenz gradient centrifugation, and the positions of ER-
GIC-53, p63 (a marker for the ER; Schweizer et al., 1995),
and GPP130 (a marker for 
 
cis/medial
 
-Golgi; Linstedt et
al., 1997) were determined by SDS-PAGE followed by im-
munoblotting. Fig. 2 
 
A
 
 shows that the gradient, run with
the KKFF (
 
1
 
tet) sample, separated ER from 
 
cis/medial
 
-
Golgi. Membranes containing endogenous ERGIC-53
cofractionated in part with ER but also appeared in a posi-
tion overlapping with 
 
cis/medial
 
-Golgi membranes, pre-
sumably representing the ERGIC. In the absence of tet,
the KKFF protein was induced (recognizable by its slightly
reduced electrophoretic mobility due to the additional
presence of a myc epitope), but its fractionation was iden-
tical to that of endogenous ERGIC-53 (Fig. 2 
 
B
 
). Obvi-
ously, overexpressed KKFF together with the endogenous
ERGIC-53 distributed normally among the organelles of
the early secretory pathway. In noninduced KKAA cells
(
 
1
 
tet), the endogenous ERGIC-53 also partitioned be-
tween ER and post-ER fractions (Fig. 2 
 
C
 
). The signal in
the ER tended to be stronger than in post-ER fractions,
presumably because of low level expression of the KKAA
protein, which accumulated in ER fractions and may have
retained some endogenous ERGIC-53 by mixed oligomer
Figure 2. Subcellular frac-
tionation on Nycodenz gradi-
ents of KKFF (A and B) and
KKAA (C and D) HeLa cells
cultured in the presence
(1tet) or absence (2tet, 48 h)
of tetracycline. Fractions were
collected from bottom (frac-
tion 1) to top (fraction 13).
The amount of marker pro-
tein in each fraction was
assessed by immunoblotting.
The blots were quantified by
phosphorimaging, and total
counts in the gradient were
set to 100% with the excep-
tion of the KKFF and the
KKAA constructs in B and
D, which were drawn in rela-
tion to the endogenously
expressed ERGIC-53. open
circles, endogenous ERGIC-
53; filled circles, transfected
ERGIC-53 construct; trian-
gles,  cis/medial-Golgi marker
GPP130;  X, ER marker p63. 
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formation. Under inducible conditions (
 
2
 
tet), both the
KKAA construct and endogenous ERGIC-53 cofraction-
ated with the ER marker at the bottom of the gradient,
and there was no indication for the presence of KKAA in
post-ER fractions (Fig. 2 
 
D
 
). We conclude that both the
KKAA protein and endogenous ERGIC-53 are retained
in the ER under these conditions.
Immunofluorescence microscopy confirmed the strik-
ingly different localization of the KKAA and KKFF con-
structs (Fig. 3 
 
A
 
). KKAA gave a typical ER pattern, while
KKFF resulted in a pattern that is characteristic for the
ERGIC with some ER staining because of the continuous
recycling of this construct (Schweizer et al., 1988; Kappeler
et al., 1997). KKAA was unable to recycle, as tested by im-
munofluorescence analysis of its localization in cells incu-
bated for 3 h at 15
 
8
 
C and after rewarming from the 15
 
8
 
C
block. The pattern of KKAA was unchanged by these tem-
perature manipulations, very much in contrast to that of
KKFF, which changed in a way that is characteristic for
ERGIC-53’s recycling (not shown; Lippincott-Schwartz et
al., 1990; Itin et al. 1995
 
b
 
; Kappeler et al., 1997).
Coimmunoprecipitation experiments were performed to
test if the KKAA construct can form disulfide-linked oli-
gomers with the endogenous ERGIC-53. KKAA cells
were cultured in tet-free medium containing [35S]methio-
nine for 3 or 15 h followed by immunoprecipitation with the
Figure 3.( A ) Binding of fluo-
rescein-labeled mannosylated
bovine serum albumin (man-
BSA). Transformed HeLa
cell lines expressing KKFF
and KKAA were incubated
48 h in the absence of tet, fixed/
permeabilized with paraform-
aldehyde/Triton X-100, and
tested for binding of man-
BSA (Itin et al., 1996). KKFF
(a) and KKAA (c) were visu-
alized with anti-myc followed
by a rhodamine-labeled sec-
ondary antibody. Man-BSA
binding was photographed
in the fluorescein channel
(b and d). (B) Localization
of b9-COP and the KKAA
construct (6 tet) by double
immunofluorescence micros-
copy. KKAA cells were fixed
with paraformaldehyde, per-
meabilized with saponine, and
subjected to immunolabeling.
b9-COP (a and c) was detected
with a specific rabbit antibody
followed by a fluorescein-con-
jugated secondary antibody.
The KKAA construct (b and
d) was visualized with an mAb
against the c-myc epitope fol-
lowed by a rhodamine-conju-
gated secondary antibody.
Note that the distribution of
b9-COP is identical regardless
of whether the KKAA con-
struct is expressed (a and b)
or not (c and d). Arrows indi-
cate ERGIC clusters. Bars:
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mAb against the myc epitope, which was present on the
KKAA construct but not on the endogenous ERGIC-53.
Although the immunoprecipitation with anti-myc was less
efficient than that with the anti–ERGIC-53 mAb, the anti-
myc antibody precipitated some endogenous ERGIC-53
together with the KKAA construct, suggesting that KKAA
can form disulfide-linked mixed oligomers with endoge-
nous ERGIC-53 (Fig. 1 C).
The restriction of the KKAA construct to the ER is not
due to misfolding since the kinetics of oligomerization of
KKAA and KKFF to dimers and hexamers were identical
and comparable to that of endogenous ERGIC-53 (not
shown, Schweizer et al., 1988). Additional evidence for cor-
rect folding was obtained by lectin binding experiments.
Lectin binding was tested by a morphological binding assay
using FITC-Man-BSA (Itin et al., 1996). 48 h after incuba-
tion with or without tet, the cells were simultaneously fixed
and detergent-permeabilized and then double-stained with
anti-myc and FITC-Man-BSA. Fig. 3 A shows colabeling
for c-myc and FITC-Man-BSA binding sites predominantly
at post-ER locations for KKFF and in the ER for KKAA. It
should be noted that most of the immunofluorescence sig-
nal originated from the overexpressed constructs, since
mock transfected cells exhibited almost no FITC-Man-BSA
binding (not shown; Itin et al., 1996).
The KKAA construct has a functional dilysine ER
retrieval signal (Jackson et al., 1990, 1993). Such dilysine
signals are known to bind COPI vesicle coat proteins
(Cosson and Letourneur, 1994). Based on the observation
that an antibody to the ERGIC-53 cytoplasmic domain
blocked the membrane recruitment of COPI in permeabi-
lized cells and inhibited the transport of vesicular stomati-
tis virus G (VSV G) from ERGIC to Golgi, it was sug-
gested that ERGIC-53 may be the major receptor for
COPI in ERGIC and cis-Golgi and thereby controls ER to
Golgi transport (Tisdale et al., 1997). In view of these find-
ings, overexpression of the KKAA construct in the ER in
conjunction with the retention of endogenous ERGIC-53
in this compartment may impair the organization of the
early secretory pathway, since under these conditions the
ERGIC would be depleted of ERGIC-53 because of its
uninhibited retrograde transport. We tested this predic-
tion by comparing the distribution of the coatomer subunit
b9-COP in induced and noninduced KKAA cells by dou-
ble immunofluorescence microscopy using a polyclonal
antibody against b9-COP and an mAb against the c-myc
epitope to visualize induction of the KKAA construct
(Fig. 3 B). Surprisingly, the distribution of b9-COP was
identical with the two conditions: Anti–b9-COP gave a
strong signal in the Golgi area and labeled discrete dots in
the cytoplasm (Fig. 3 B, a and c) known to represent ER-
GIC clusters (Oprins et al., 1993; Itin et al., 1995a; Rowe
et al., 1996). The cis/medial-Golgi was also unchanged as
visualized with an mAb against giantin (not shown). Thus,
the mistargeting of ERGIC-53 does not result in gross
morphological changes of the early secretory pathway.
Glycoprotein Secretion in KKAA and KKFF Cells
Pulse-chase experiments were performed to test whether
overexpression of the KKAA and KKFF constructs affects
the secretion of glycoproteins. After a 48-h incubation 6
tet, stably transfected cells were labeled with [35S]methio-
nine for 30 min followed by a chase for up to 3 h. Secreted
glycoproteins were affinity-isolated from the medium with
Con A–Sepharose, eluted with 0.5 M a-methylmannoside,
and analyzed by SDS-PAGE and fluorography. Fig. 4 A
shows the pattern of secreted glycoproteins obtained for
the KKAA and the KKFF cell lines. Endo F digestion as-
certained that these proteins were indeed glycoproteins
since all of them underwent a mobility shift (not shown).
Within 1 h of chase, a major 57-kD glycoprotein showed
reduced secretion in cells overexpressing KKAA (2tet),
while the other major secreted glycoproteins were unaf-
fected under these conditions. Similarly, at 2 and 3 h of
chase, the 57-kD protein was the only major glycoprotein
affected by overexpressing KKAA. Laser scanner densito-
metry of the fluorograms was used to quantify the differ-
ence in 57-kD secretion of induced versus noninduced
cells. As indicated in Fig. 4 B, the secretion of this protein
was reduced eightfold after 1 h, fourfold after 2 h, and
twofold after 3 h of chase. To investigate if the reduced
amounts of the 57-kD protein in the medium of KKAA
cells is due to a delay of secretion or to reduced biosynthe-
sis, pulse-chase experiments with extended chase times
were performed. Fig. 4 C shows that the difference in se-
cretion of the 57-kD protein gradually disappeared with
time. It was still detectable after 6 h (2.5-fold reduction)
and 12 h (1.7-fold reduction) but no longer after 24 h of
chase, supporting the interpretation of a secretion delay.
Cells overexpressing the KKFF construct exhibited nor-
mal glycoprotein secretion including the 57-kD protein
(Fig. 4 A). Prolonged tet withdrawal for up to 9 d resulted
in the same secretion phenotype (not shown). Thus, mis-
targeting of ERGIC-53 to the ER resulted in a selective
secretion phenotype that did not affect the viability of
HeLa cells.
Identification of the Inefficiently Secreted 57-kD 
Glycoprotein as Procathepsin C
To identify the 57-kD protein, it was purified from the cul-
ture medium of KKFF cells 24 h after plating the cells.
Glycoproteins were isolated by Con A–Sepharose, sepa-
rated by SDS-PAGE, and blotted onto a polyvinyl difluo-
ride membrane. The 57-kD region was excised and sub-
jected to tryptic digestion. Tryptic peptides were isolated
by reverse-phase column chromatography and sequenced.
The sequence of three peptides was established, all of
which were found to belong to the sequence of procathep-
sin C, a precursor of the lysosomal enzyme cathepsin C, by
database searches (Fig. 5).
Because the 57-kD region may include several glycopro-
teins, it was important to establish if the inefficiently se-
creted glycoprotein was indeed procathepsin C. To test
this, an antibody against rat cathepsin C was used (Muno
et al., 1993), since no antibody against human cathepsin C
was available. This antibody was found to cross-react with
the human enzyme (Fig. 6 A). It precipitated a protein of
z57-kD from metabolically labeled FAO rat hepatoma
cells and human HeLa (KKAA) cells in reasonable agree-
ment with the known molecular mass of procathepsin C
(Muno et al., 1993). In the next step, we analyzed the cul-
ture media for secreted procathepsin C. KKAA cells were 
Vollenweider et al. 
 
A Role of ERGIC-53 in Secretion
 
383
 
cultured 
 
6 
 
tet for 48 h, labeled with [
 
35
 
S]methionine for 30
min, and chased for 2 h with unlabeled methionine in ex-
cess. Glycoproteins were isolated with Con A–Sepharose,
immunoprecipitated with anti–procathepsin C, and ana-
lyzed by SDS-PAGE and fluorography. This experiment
identified the inefficiently secreted 57-kD band as pro-
cathepsin C (Fig. 6 
 
A
 
, 
 
Cat C
 
). Direct immunoprecipitation
of the antigen from the medium omitting the Con A step
gave identical results (Fig. 6 
 
B
 
, lanes 
 
3
 
 and 
 
4
 
) and showed
that the majority of the glycoprotein in the 57-kD region
of the gel is due to secreted procathepsin C. That the tet-
dependent decrease of procathepsin C in the medium was
not due to reduced synthesis was confirmed by metabolic
labeling. After a 10-min pulse with [
 
35
 
S]methionine, identi-
cal amounts of metabolically labeled procathepsin C were
immunoprecipitable from cells cultured 
 
6 
 
tet (not shown).
The inefficient secretion of procathepsin C was not due to
clonal variation since three independent KKAA clones ex-
hibited the same phenotype (Fig. 7).
The secreted glycoproteins were also analyzed by two-
dimensional (2D) gel electrophoresis. To this end, cells
cultured 
 
6 
 
tet were labeled with [
 
35
 
S]methionine for 30
min and chased for 3 h with unlabeled methionine in ex-
cess. Secreted glycoproteins were isolated with Con A
beads and separated by isoelectric focusing in the first di-
mension followed by SDS-PAGE in the second dimen-
sion. To identify procathepsin C, the protein was immuno-
precipitated from a KKAA culture (
 
1
 
tet) labeled in
parallel and also subjected to the 2D gel electrophoresis.
Fig. 8 confirms that the major glycoprotein affected by tet
withdrawal is procathepsin C. On 2D gels, procathepsin C
appeared as a cohort of spots in the pI range 6 to 7, which
Figure 4. Secretion of glycoproteins in KKFF and KKAA HeLa cells. (A)
Cells were incubated for 48 h 6 tet, labeled for 30 min with [35S]methionine
and chased for 1, 2, and 3 h. Glycoproteins were isolated with Con A beads
and separated by 10% SDS-PAGE. 14C-labeled molecular mass markers are
indicated at the right margin (200, 97.4, 66, 46, and 30 kD). The arrows indi-
cate the position of the 57-kD protein. *, band used as a reference for quanti-
fication in B. The apparent absence of the 66-kD protein in the KKFF panel
(3 h, 2tet) is due to an artifactual inhomogeneity of the gel. (B) Quantifica-
tion of the delay in secretion of the 57-kD glycoprotein. The amount of the
57-kD glycoprotein was determined by densitometry of fluorograms and nor-
malized. Shown is the relative secretion as determined by dividing the value
obtained for 2tet by that for 1tet. Values are means 6 SEM of at least three
independent experiments. white bars, KKFF; black bars, KKAA. (C) Tet-
dependent difference in the secretion of the 57-kD protein disappears with
increased chase times. KKAA cells were treated 6 tet for 48 h, pulsed for 30
min with [35S]methionine, and chased for 2, 6, 12, and 24 h. Glycoproteins
were isolated from the culture medium and analyzed by SDS-PAGE as in A.
Figure 5. The sequence of three peptides isolated from the 57-kD
protein can be accommodated within the amino acid sequence of the
precursor of the human lysosomal peptidase procathepsin C (Paris et
al., 1995). Shown is part of the deduced partial amino acid sequence
of human procathepsin C and the sequence of three tryptic peptides
determined by automatic sequencing (bold and underlined).
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is in reasonable agreement with the calculated pI 7.0 de-
duced from the primary sequence of human procathepsin
C (Paris et al., 1995). The secretion of a few minor glyco-
proteins of unknown identity, e.g., in the 45-kD/pI 7 range,
also appeared to be reduced in the absence of tet.
To further confirm the identity of the 57-kD protein, the
antigen was immunoprecipitated from the culture medium
and digested with endo F and endo H. Endo F digestion
reduced the apparent molecular mass to 
 
z
 
5 kD (Fig. 6 
 
B
 
,
lane 
 
7
 
). Endo H treatment resulted in several bands, sug-
gesting considerable endo H sensitivity of the secreted
form (Fig. 6 
 
B
 
, lane 
 
6
 
). Limited digestion with Endo H of
the protein immunoprecipitated from cell extracts pro-
duced up to five bands (Fig. 6 
 
B
 
, lane 
 
9
 
). These results sug-
gest that the 57-kD protein recognized by the anticathep-
sin antibody carries four N-linked glycans. Consistent with
this, the cDNA of procathepsin C has four consensus sites
for 
 
N
 
-glycosylation (Paris et al., 1995).
Is delayed secretion associated with ERGIC-53’s mis-
localization a specific feature of lysosomal enzymes? This
does not appear to be the case. Cathepsin D, known to
carry two 
 
N
 
-glycosidic side chains (Hasilik and Neufeld,
1980), was secreted with identical kinetics in KKAA cells
 
 6
 
tet (Fig. 9 
 
B
 
). 
 
a
 
-Glucosidase, a lysosomal enzyme having
seven potential 
 
N
 
-glycosylation sites (Hermans et al., 1993)
was not secreted into the culture medium. Previous studies
suggested that this enzyme is membrane bound (Fransen et
al., 1988; Wisselaar et al., 1993). Transport of 
 
a
 
-glucosidase
to lysosomes was unchanged by overexpressing KKAA in
the ER, as indicated by the kinetics of appearance of the
different maturation forms of the protein (Fig. 9 
 
C
 
). We
next studied the transport of the endosomal marker trans-
ferrin receptor, a membrane glycoprotein with three
N-linked glycans, one of which remains in a high mannose
form (Enns et al., 1991). Transport from ER to 
 
medial
 
-
Golgi was found to be unaffected by overexpressing KKAA
in the ER as monitored by the acquisition of endo H resis-
tance (Fig. 9 
 
A
 
). Likewise, the transport of the plasma
membrane protein aminopeptidase N (10 
 
N
 
-glycosylation
sites; Olsen et al., 1988) and the lysosomal membrane glyco-
protein Lamp 1 (18 
 
N
 
-glycans; Carlsson et al., 1988) was not
affected by mislocalizing ERGIC-53 to the ER (not shown).
 
Overexpression of KKAA Delays ER Exit of 
Procathepsin C
 
Is the inefficient secretion of procathepsin C due to a de-
lay in ER–Golgi transport? Because procathepsin C was
found to remain endo H sensitive during its passage
through the Golgi apparatus (not shown), we were unable
to approach this question by monitoring the acquisition of
complex glycans. Likewise, a morphological approach
failed since the antibody was not useful for immunofluo-
rescence microscopy. Therefore, we used subcellular frac-
tionation. KKAA cells cultured for 48 h 
 
6 
 
tet were pulsed
for 15 min with [
 
35
 
S]methionine and chased for 30 and 60
min. Postnuclear supernatants were separated on Nyco-
denz gradients, the ER fractions (fractions 1–5) were
pooled, and procathepsin C was immunoprecipitated and
Figure 6. The inefficiently secreted 57-kD protein is procathep-
sin C. (A, left) Procathepsin C expression in FAO and HeLa cells.
FAO and KKAA (6 tet, 48 h) cells were labeled for 30 min with
[35S]methionine and immunoprecipitated with an antibody against
rat cathepsin C. Immunoprecipitated proteins were separated by
10% SDS-PAGE. (Right) Glycoproteins isolated by Con A beads
and immunoprecipitation of procathepsin C. KKAA 6 tet (48 h)
cells were pulsed for 30 min and chased for 2 h. Secreted glyco-
proteins released from Con A beads (Con A) were lyophilized,
immunoprecipitated with the cathepsin C antibody, and sepa-
rated by 10% SDS-PAGE (Cat C). (B) Direct immunoprecipita-
tion of procathepsin C from the culture medium and digestion
with glycosidases. KKAA in the presence or absence of tet (48 h)
cells were pulsed for 30 min and chased for 2 h. The medium
(lanes 1–7) was subjected to methanol precipitation, and the pre-
cipitate was resuspended and immunoprecipitated with the cathe-
psin C antibody. Immunoprecipitates were digested with endo H
under nonlimiting (lane 6) and limiting (lane 9, sample was from
detergent-solubilized cells) conditions or with endo F as indicated
and separated by SDS-PAGE.
Figure 7. Inefficient secretion of procathepsin C is not due to
clonal variation. Cells of clones KKAA 1, KKAA 15, KKAA 4
(used in this study), and KKFF 9 cells were cultured in the pres-
ence or absence of tet for 48 h followed by labeling for 30 min
with [35S]methionine and a chase of 2 h. Proteins released into the
culture medium were methanol precipitated. The precipitates
were resuspended and immunoprecipitated with anti–cathepsin C
antibody. The immunoprecipitates were separated by SDS-
PAGE and radiolabeled proteins were visualized by fluorography. 
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its radioactivity quantified by densitometric scanning after
SDS-PAGE (Fig. 10). Under noninducible conditions,
25% of the initially synthesized procathepsin C disap-
peared from the pooled ER fractions after 30 min of chase
and 59% after 60 min. Under inducible conditions, these
values were 4% after 30 min and 35% after 60 min. These
data suggest that overexpression of the KKAA construct
delays transport of procathepsin C from the ER, although
they do not indicate whether or not ER exit is the only
rate-limiting transport step.
 
Discussion
 
In this study, we report that mistargeting of ERGIC-53 to
the ER by overexpressing the KKAA construct led to a
limited secretion phenotype resulting in the delayed secre-
Figure 8. 2D gel analysis of secreted glycoproteins. KKAA cells were
cultured in the absence (A) or presence (B) of tet for 48 h. Thereafter,
the cells were labeled for 30 min with [35S]methionine and chased for 3 h.
Secreted glycoproteins were isolated with Con A beads, methanol
precipitated, and subjected to isoelectric focusing (15 h) in the first di-
mension using a 3–10 linear immobiline pH gradient. 10% SDS-PAGE
was used for the second dimension. As a reference, cathepsin C was im-
munoprecipitated from the medium of KKAA cells (1tet) that had
been labeled in parallel and subjected to the same 2D gel separation
procedure (C). Proteins were visualized by fluorography.The Journal of Cell Biology, Volume 142, 1998 386
tion of procathepsin C from HeLa cells, while overexpres-
sion of KKFF, a myc-tagged wild-type ERGIC-53, had no
effect on glycoprotein secretion.
The rationale of our approach was to mistarget an exog-
enous mutant ERGIC-53 to the ER and due to overex-
pression and mixed oligomer formation block the recy-
cling of endogenous ERGIC-53 in this compartment. If
ERGIC-53 is essential for glycoprotein transport, such a
functional inactivation of ERGIC-53 should result in a se-
cretion phenotype. To minimize the possibility of upregu-
lation of a mechanism that may compensate for the func-
tional inactivation of ERGIC-53, an inducible expression
system was chosen. Our results suggest that in the KKAA
clone the expected mistargeting of both KKAA and en-
dogenous ERGIC-53 was indeed achieved under inducible
conditions (2tet). Immunofluorescence microscopy and
density gradient analysis suggest that both the KKAA and
endogenous ERGIC-53 were apparently quantitatively re-
tained in the ER. That KKAA constructs are unable to
leave the ER has also been noted in other cell types (Kap-
peler et al., 1997).
The precise mechanism by which the KKAA construct
retained endogenous ERGIC-53 in the ER remains to be
elucidated. We assume that mixed oligomer formation is a
major mechanism by which this is achieved. It is unlikely,
however, that disulfide bond–mediated oligomerization
entirely accounts for this effect. Only the newly synthe-
sized but not the already existing endogenous ERGIC-53,
which has a rather long half-life (Schweizer et al., 1988),
can form disulfide bonds with the KKAA construct during
induction. ERGIC-53 may form higher order oligomers
that are not covalently linked and therefore do not survive
coimmunoprecipitation as used in the present study. We
also noted some downregulation of the endogenous ER-
GIC-53 by overexpressing the KKAA constructs (not
shown).
ERGIC-53’s cytosolic domain can bind COPI because
of its KKFF dilysine ER retrieval signal (Schindler et al.,
1993; Kappeler et al., 1997; Tisdale et al., 1997). An anti-
body against this domain was reported to block the re-
cruitment of COPI to the ERGIC in permeabilized cells
and to inhibit transport of VSV G glycoprotein from ER-
GIC to Golgi (Tisdale et al., 1997). The authors proposed
that ERGIC-53 is required for selective transport through
the early secretory pathway by serving as a major COPI-
binding receptor in ERGIC and cis-Golgi. If ERGIC-53
would operate as the major receptor, its depletion from the
Figure 9. Intracellular trans-
port of identified glycopro-
teins in KKAA cells (treated
in the presence or absence of
tet for 48 h). (A) Transferrin
receptor: Cells were pulsed
for 10 min with [35S]methio-
nine and chased as indicated.
The receptor was immuno-
precipitated from the Triton
X-100–solubilized cells and di-
gested (or not) with endo H.
(B) Cathepsin D: Cells were
metabolically labeled for 1 h
followed by a chase for 3 or
6 h. The culture medium was
precipitated with methanol.
Cathepsin D was immunopre-
cipitated from the resus-
pended methanol precipitate.
(C) a-Glucosidase: Cells were
metabolically labeled for 1 h
and chased as indicated, and
the enzyme was immunopre-
cipitated after cell solubiliza-
tion with Triton X-100. The
immunoprecipitates were sep-
arated by SDS-PAGE and
visualized by fluorography.
Figure 10. Overexpression of
the KKAA construct delays
ER exit of procathepsin C.
KKAA cells were cultured in
presence or absence of tet for
48 h and pulse-labeled with
[35S]methionine and chased
for the indicated times. The
cells were homogenized, and
membranes were separated by Nycodenz gradient centrifugation
(see Materials and Methods). Fractions 1–5 containing the ER
marker p63 were pooled and Triton X-100 solubilized, and pro-
cathepsin C was immunoprecipitated. The immunoprecipitates
were separated by SDS-PAGE, and procathepsin C was quanti-
fied from the fluorogram. The start signal after the pulse was set
to 100%. All the lanes of this figure originate from the same fluo-
rogram and were identically exposed. They had to be rearranged
for reproduction purposes.Vollenweider et al. A Role of ERGIC-53 in Secretion 387
ERGIC should lead to COPI dissociation from the mem-
branes of the early secretory pathway. At variance with this
notion, by immunofluorescence microscopy we find no
change in the localization of COPI when ERGIC-53 is
absent from post-ER sites by the mistargeting of KKAA to
the ER. Indeed, our immunofluorescence experiments did
not reveal any gross morphological changes of the early
secretory pathway under these conditions. In particular,
ERGIC clusters visualized by b9-COP were equally abun-
dant in KKAA cells 6 tet. The apparent discrepancy be-
tween Tisdale et al. (1997) and our data are not easy to ex-
plain but may be caused by experimental differences. While
the study of Tisdale et al. (1997) was performed with semi-
intact cells, our present study is based on intact cells and
hence is closer to physiology. Clearly, cells not expressing
any ERGIC-53 will be required to resolve the discrepancy.
Mistargeting of ERGIC-53 to the ER resulted in a
rather limited secretion phenotype. It appears that in
HeLa cells, the recycling of ERGIC-53 is essential for the
efficient secretion of one major glycoprotein, procathepsin
C, and a few minor glycoproteins, as indicated by our 2D
gel analysis, whereas it is not essential for the majority of
glycoproteins. Cathepsin D and a-glucosidase, two other
lysosomal enzymes, were not affected by ERGIC-53’s mis-
targeting. Likewise, locking ERGIC-53 to the ER did not
impair the transport from ER to medial-Golgi of the
plasma membrane protein aminopeptidase N, the endoso-
mal membrane protein transferrin receptor, and the lyso-
somal membrane protein lamp1. That the transport of
lamp1 was unaffected is particularly noteworthy since this
protein carries 18 N-linked glycans (Carlsson et al., 1988).
How does the retention of ERGIC-53 in the ER affect
the transport of procathepsin C? Consistent with its man-
nose-selective lectin activity in vitro, ERGIC-53 may be
required for the efficient export of procathepsin C from
the ER. This notion is supported by our finding that ER
exit of procathepsin C is delayed by overexpressing the
KKAA protein, although the data do not allow us to con-
clude that ER exit is the only delayed transport step. It is
interesting to note that procathepsin C is a tetramer
(Muno et al., 1993), in contrast to the nonaffected lysoso-
mal enzymes cathepsin D and a-glucosidase, which are
monomers (Hasilik and Neufeld, 1980). It is conceivable,
therefore, that proteins carrying many N-linked glycans
require ERGIC-53 for efficient transport. A tetramer of
cathepsin C would amount to 16 glycans. However, the ab-
solute number of oligosaccharide side chains may not be
the only criterion since the transport of Lamp1 carrying 18
N-linked glycans was unaffected by the mistargeting of
ERGIC-53. Our attempts to demonstrate direct interac-
tion of procathepsin C and ERGIC-53 by coimmunopre-
cipitation have been unsuccessful, suggesting that this in-
teraction, if existent, must be of low affinity. Alternatively,
the effect on procathepsin C transport may be indirect.
ER-retained ERGIC-53 may bind and disturb a glycopro-
tein cofactor required for the maturation or transport of
cathepsin C. Whatever the precise mechanism, the result
with cathepsin C demonstrates the first lectin effect of ER-
GIC-53 in vivo.
The role of carbohydrates in ER-to-Golgi traffic re-
mains unclear. Even though ERGIC-53 does not appear to
be essential for the transport of most glycoproteins in
HeLa cells, the hypothesis of lectin-mediated transport
(Fiedler and Simons, 1995; Itin et al., 1996) remains attrac-
tive. Carbohydrate-dependent transport may involve more
than one lectin, so that the inactivation of one of them, as
in the case of ERGIC-53, may be compensated largely by
other lectins. If such lectins are not homologous to ER-
GIC-53 and VIP36, they may be difficult to detect. ER-
GIC-53 and VIP36 are so far the only members of this
novel family of animal lectins. ERGIC-53 is conserved all
the way from Caenorhabditis elegans to Xenopus, rat, and
man. Of particular importance, this conservation includes
the CRD in which the amino acids critical for sugar bind-
ing in leguminous lectins are invariant, and the cytosolic
tail carrying ER export and ER retrieval signals (Kappeler
et al., 1997). In a recent study, mutations in ERGIC-53
were found to lead to an autosomal recessive bleeding dis-
order in humans termed combined deficiency of coagula-
tion factors V and VIII (Nichols et al., 1998). Although the
mechanism by which ERGIC-53 is required for maintain-
ing appropriate serum levels of the homologous coagula-
tion factors V and VIII remains to be elucidated, this study
is in agreement with our conclusion drawn from a cell cul-
ture system that ERGIC-53 is required for efficient secre-
tion of a limited set of glycoproteins. ERGIC-53 may act
as a traffic chaperone for these proteins. That ERGIC-53
is already expressed in C. elegans (our unpublished obser-
vations) strongly suggests that this protein has functions in
addition to regulating blood coagulation.
The effect of inactivation of ERGIC-53 is reminiscent of
a deletion of emp24 gene in yeast leading to a selective se-
cretion phenotype involving the two proteins invertase
and Gas1p (Schimmöller et al., 1995). This finding led to
the hypothesis that Emp24p may act as a transport recep-
tor for these proteins, but it is unknown if Emp24p directly
binds these cargo proteins, and hence this suggestion re-
mains to be proven.
In summary, while the precise function of ERGIC-53 re-
mains to be established, the present study suggests that this
protein is essential for the efficient transport of at least one
glycoprotein in HeLa cells. Furthermore, mistargeting of
ERGIC-53 to the ER does not alter the gross morphology
of the early secretory pathway, indicating that this protein
is not required for the maintenance of the ERGIC.
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